Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors

Kidney International

Volumn 68, Issue 5, 2005, Pages 2189-2196

  Ferrario, Carlos M ^a   Jessup, Jewell ^a   Gallagher, Patricia E ^a   Averill, David B ^a   Brosnihan, K Bridget ^a   Tallant, E Ann ^a   Smith, Ronald D ^a   Chappell, Mark C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

Angiotensin (1 7); Angiotensin converting enzyme 2; Hypertension; Lisinopril; Losartan; Renal function

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN[1-7]; ANGIOTENSINOGEN; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE 2; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DRINKING WATER; ENZYME; HEPTAPEPTIDE; LISINOPRIL; LOSARTAN; MEMBRANE METALLOENDOPEPTIDASE; MESSENGER RNA; RECEPTOR; UNCLASSIFIED DRUG;

ANGIOTENSIN BLOOD LEVEL; ANIMAL EXPERIMENT; ARTERIAL PRESSURE; BLOOD PRESSURE; BLOOD PRESSURE REGULATION; BLOOD SAMPLING; CONFERENCE PAPER; CONTROLLED STUDY; CREATININE URINE LEVEL; DRUG EFFECT; ENZYME ACTIVITY; FLUID INTAKE; KIDNEY CORTEX; LEUKOCYTE; MALE; MEASUREMENT; NONHUMAN; OSMOLALITY; POLYURIA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; URINARY EXCRETION; URINE LEVEL; URINE VOLUME;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CARBOXYPEPTIDASES; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HYPERTENSION, RENAL; KIDNEY; LISINOPRIL; LOSARTAN; MALE; PEPTIDE FRAGMENTS; PEPTIDYL-DIPEPTIDASE A; RATS; RATS, INBRED LEW; RECEPTORS, ANGIOTENSIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 30944453306     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2005.00675.x     Document Type: Conference Paper

References (34)

1. RICE GI, THOMAS DA, GRANT PJ, et al: Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism. Biochem J 383:45-51, 2004
2. YAGIL Y, YAGIL C: Hypothesis: ACE2 modulates blood pressure in the mammalian organism. Hypertension 41:871-873, 2003
3. CHAPPELL MC, MODRALL JG, DIZ DI, FERRARIO CM: Novel aspects of the renal renin-angiotensin system: Angiotensin-(1-7), ACE2 and blood pressure regulation. Contrib Nephrol 143:77-89, 2004
4. CRACKOWER MA, SARAO R, OUDIT GY, et al: Angiotensin-converting enzyme 2 is an essential regulator of heart function. Nature 417:822-828, 2002
5. FERRARIO CM, CHAPPELL MC, TALLANT EA, et al: Counterregulatory actions of angiotensin-(1-7). Hypertension 30:535-541, 1997
6. FERRARIO CM, JESSUP JA, CHAPPELL MC, et al: Effect of angiotensin converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin converting enzyme 2. Circulation 111:2605-2610, 2005
7. ISHIYAMA Y, GALLAGHER PE, AVERILL DB, et al: Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors. Hypertension 43:970-976, 2004
8. AVERILL DB, ISHTYAMA Y, CHAPPELL MC, FERRARIO CM: Cardiac angiotensin-(1-7) in ischemic cardiomyopathy. Circulation 108:2141-2146, 2003
9. LOOT AE, ROKS AJ, HENNING RH, et al: Angiotensin-(1-7) attenuates the development of heart failure after myocardial infarction in rats. Circulation 105:1548-1550, 2002
10. IGASE M, STRAWN WB, GALLAGHER PE, et al: Angiotensin ii AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 289:H1013-H1019, 2005
11. FERRARIO CM, AVERILL DB, BROSNIHAN KB, et al: Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat. Kidney Int 62:1349-1357, 2002
12. ALLRED AJ, DIZ DI, FERRARIO CM, CHAPPELL MC: Pathways for angiotensin-(1-7) metabolism in pulmonary and renal tissues. Am J Physiol 279:F841-F850, 2000
13. DALES NA, GOULD AE, BROWN JA, et al: Substrate-based design of the first class of angiotensin-converting enzyme-related carboxypeptidase (ACE2) inhibitors. J Am Chem Soc 124:11852-11853, 2002
14. IYER SN, CHAPPELL MC, AVERILL DB, et al: Vasodepressor actions of angiotensin-(1-7) unmasked during combined treatment with lisinopril and losartan. Hypertension 31:699-705, 1998
15. NAKAMURA S, AVERILL DB, CHAPPELL MC, et al: Angiotensin receptors contribute to blood pressure homeostasis in salt-depleted SHR. Am J Physiol Regul Integr Comp Physiol 284:R164-R173, 2003
16. YAMADA K, IYER SN, CHAPPELL MC, et al: Differential response of angiotensin peptides in the urine of hypertensive animals. Regul Pept 80:57-66, 1999
17. CHAPPELL MC, PIRRO NT, SYKES A, FERRARIO CM: Metabolism of angiotensin-(1-7) by angiotensin converting enzyme. Hypertension 31:362-367, 1998
18. VICKERS C, HALES P, KAUSHIK V, et al: Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase. J Biol Chem 277:14838-14843, 2002
19. WELCHES WR, BROSNIHAN KB, FERRARIO CM: A comparison of the properties, and enzymatic activity of three angiotensin processing enzymes: Angiotensin converting enzyme, prolyl endopeptidase and neutral endopeptidase 24.11. Life Sci 52:1461-1480, 1993
20. FERRARIO CM, SMITH RD, BROSNIHAN KB, et al: Effects of omapatrilat on the renin angiotensin system in salt sensitive hypertension. Am J Hyperten 15:557-564, 2002
21. LUQUE M, MARTIN P, MARTELL N, et al: Effects of captopril related to increased levels of prostacyclin and angiotensin-(1-7) in essential hypertension. J Hypertens 14:799-805, 1996
22. GEMBARDT F, STERNER-KOCK A, IMBODEN H, et al: Organ-specific distribution of ACE2 mRNA and correlating peptidase activity in rodents. Peptides 26:1270-1277, 2005
23. FERRARIO CM, IYER SN: Angiotensin-(1-7): A bioactive fragment of the renin-angiotensin system. Regul Pept 78:13-18, 1998
24. DANILCZYK U, ERIKSSON U, OUDIT GY, PENNINGER JM: Physiological roles of angiotensin-converting enzyme 2. Cell Mol Life Sci 61:2714-2719, 2004
25. BROSNIHAN KB, NEVES LA, JOYNER J, et al: Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy. Hypertension 42:749-753, 2003
26. DOUGLAS GC, O'BRYAN MK, HEDGER MP, et al: The novel angiotensin- converting enzyme (ACE) homolog, ACE2, is selectively expressed by adult Leydig cells of the testis. Endocrinology 145:4703-4711, 2004
27. LELY AT, HAMMING I, VAN GH, NAVIS GJ: Renal ACE2 expression in human kidney disease. J Pathol 204:587-593, 2004
28. TIKELLIS C, JOHNSTON CI, FORBES JM, et al: Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy. Hypertension 41:392-397, 2003
29. LI N, ZIMPELMANN J, CHENG K, et al: The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules. Am J Physiol Renal Physiol 288:F353-F362, 2005
30. TURNER AJ: Exploring the structure and function of zinc metallopeptidases: Old enzymes and new discoveries. Biochem Soc Trans 31:723-727, 2003
31. ZISMAN LS, KELLER RS, WEAVER B, et al: Increased angiotensin-(1-7)- forming activity in failing human heart ventricles: Evidence for upregulation of the angiotensin-converting enzyme Homologue ACE2. Circulation 108:1707-1712, 2003
32. ZISMAN LS, MEIXELL GE, BRISTOW MR, CANVER CC: Angiotensin-(1-7) formation in the intact human heart: In vivo dependence on angiotensin II as substrate. Circulation 108:1679-1681, 2003
33. ZHONG JC, HUANG DY, YANG YM, et al: Upregulation of angiotensin- converting enzyme 2 by all-trans retinoic acid in spontaneously hypertensive rats. Hypertension 44:907-912, 2004
34. FERRARIO CM, AVERILL DB, BROSNIHAN KB, et al: Angiotensin-(1-7): Its contributions to arterial pressure control mechanisms, in Handbook of Experimental Pharmacology: Angiotensin (Vol 1), edited by Unger T, Scholkens BA, Heidelberg, Germany, 2004, pp 478-518